NovaBay Pharmaceuticals Inc
AMEX:SDEV
Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
|
O
|
OncoCyte Corp
LSE:0KCC
|
US |
|
S
|
Shivalik Rasayan Ltd
NSE:SHIVALIK
|
IN |
|
Swiss Life Holding AG
LSE:0QMG
|
CH |
NovaBay Pharmaceuticals Inc
Umsatz
NovaBay Pharmaceuticals Inc
Umsatz Peer-Vergleich
NovaBay Pharmaceuticals Inc
Kurzansicht
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 29 full-time employees. The company went IPO on 2007-10-26. The firm develops and sells scientifically created and clinically proven eyecare and skincare products. Its product, Avenova Antimicrobial Lid & Lash Solution is used for blepharitis and dry-eye disease and is also available directly to eyecare consumers through online distribution. Its trademarks include Avenova, CelleRx, PhaseOne, NeutroPhase, DERMAdoctor, Kakadu C, AINT Misbehavin, KP Duty, and depictions of Dr. Audrey Kunin. Avenova Spray has broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. The Company, through its subsidiary DERMAdoctor, LLC, offers approximately 30 dermatologist-developed products targeting common skin concerns, ranging from aging and blemishes to dry skin, perspiration, and keratosis pilaris.
Auch interessant
Wie hoch ist Umsatz von NovaBay Pharmaceuticals Inc?
Umsatz
521k
USD
Laut Finanzbericht vom Dec 31, 2025 beträgt Umsatz von NovaBay Pharmaceuticals Inc 521k USD.
Wie hoch ist die Wachstumsrate von Umsatz bei NovaBay Pharmaceuticals Inc?
Umsatz CAGR 10J
-19%
Im letzten Jahr lag das Wachstum von Umsatz bei -95%. Die durchschnittlichen jährlichen Wachstumsraten von Umsatz bei NovaBay Pharmaceuticals Inc lagen bei -67% über die letzten drei Jahre , -45% über die letzten fünf Jahre und -19% über die letzten zehn Jahre .
